9.73
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
210.29%
0.965
|
0.311 | 0.606 | 1.25 | 1.061 |
|
0.11%
19.53
|
19.55 | 21.19 | 21.40 | 27.48 |
Benefits Costs and Expenses |
138.87%
16.64
|
-42.82 | 82.73 | 20.42 | -4.189 |
Costs And Expenses |
138.87%
16.64
|
-42.82 | 82.73 | 20.42 | -4.189 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
3.51%
-18.57
|
-19.24 | -20.56 | -20.13 | -26.41 |
Net Interest Income/Expense |
50.00%
0.40
|
0.80 | 0.30 | 0.50 | 0.30 |
Interest Income/Expense After Provision For Losses |
50.00%
0.40
|
0.80 | 0.30 | 0.50 | 0.30 |
Income/Loss From Continuing Operations Before Tax |
136.35%
-15.68
|
43.13 | -82.12 | -19.17 | 5.25 |
Income Tax Expense/Benefit |
330.23%
0.185
|
0.043 | 0.027 | 0.091 | 0.189 |
Income/Loss From Continuing Operations After Tax |
136.82%
-15.86
|
43.09 | -82.15 | -19.26 | 5.061 |
|
136.82%
-15.86
|
43.09 | -82.15 | -19.26 | 5.061 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
23.10%
10.35
|
8.4085 | 0.00591 | 6.2723 | 156.44 |
Diluted Average Shares |
18.85%
10.35
|
8.7097 | 0.00591 | 6.2723 | 156.65 |
Basic Earnings Per Share |
129.88%
-1.53
|
5.12 | -13.10 | -3.07 | 0.03 |
Diluted Earnings Per Share |
27.49%
-1.53
|
-2.11 | -13.10 | -3.07 | 0.03 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):